The Truth About Canadian Doctors and Menopause Training

If you have ever brought up perimenopause or menopause with your family doctor and walked out feeling brushed off, half-heard, or handed a prescription without much of a conversation, this article is for you. That experience is common, it is frustrating, and it is usually not a sign that your doctor does not care. More often it points to something larger and quieter: a system that never fully trained them for this, and does not pay them well to take the time it requires.

This is a longer, more detailed piece than most on this site, because the question deserves a careful answer. We are going to look at what Canadian family doctors are taught about menopause, how the billing system shapes the visit you end up getting, and where all of that leaves women looking for help. The sources are linked so you can read them for yourself. None of this is meant to make you distrust your doctor. It is meant to help you understand the room you are walking into, so you can make the most of it.

Start with medical school. In 2021, two Toronto researchers, Natalie Anderson and Anna Gagliardi, went through the published curriculum at sixteen of Canada’s seventeen medical schools, more than fourteen hundred course and program documents in all. Women’s health was mentioned in just 8.6 percent of them, and at some schools it did not appear at all. When they narrowed to the principles and practice of women’s health, rather than passing references, the figure fell below two percent. Menopause sits inside that thin slice.

A closer look at one school tells the same story from another angle. A review of the University of British Columbia’s program found that of the 93 women’s health competencies students are expected to learn, 60 of them were being taught in just one place: the third-year obstetrics and gynaecology clerkship, one of fourteen possible teaching settings across the four-year program. Menopause is among those competencies, but perimenopause, the transition that can last four to ten years and is often when symptoms are most disruptive, is not treated as a distinct subject. That may help explain why so many women in the thick of the transition are missed entirely. The review confirmed the topics appeared on paper, but could not confirm how thoroughly they were actually delivered. This is not a new worry. As far back as 1994, ninety percent of Canadian family medicine program directors surveyed described the teaching of women’s health in their own programs as inadequate.

The College of Family Physicians of Canada lists menopause as a certification objective for family medicine, yet a 2022 international review of medical curricula worldwide concluded that, despite being a stated objective, family-doctor exposure to menopause education remains minimal, and that training on the subject is, in its own words, profoundly inadequate. One Toronto-based doctor, writing in Canadian Family Physician, noted plainly that many primary care clinicians have had little experience treating menopausal patients, and developed a six-question screening tool specifically to help fill that gap at the bedside.

The most detailed numbers on how unprepared this leaves doctors come from the United States. The largest study of its kind surveyed family medicine, internal medicine, and obstetrics and gynaecology residents across twenty US programs. Nearly all of them, 93.8 percent, said training in menopause was important. Only 6.8 percent felt adequately prepared to provide it. More than a third said they were not prepared at all, one in five had received no menopause lectures during their entire residency, and a third said they would not offer hormone therapy to a healthy, newly menopausal woman who was a clear candidate for it. A separate American review found that trainees in most programs received no more than an hour or two of menopause instruction across the whole of their training. These are American figures, and will be labelled as such throughout. Canadian family medicine experts have pointed to the same knowledge gap in their own research and writing, and as the next section explains, both countries were shaped by the same turning point.

Doctors are not failing women out of indifference. Most were never given the training, or the time, that good menopause care demands.

To understand why menopause care lost its footing in medical training, you have to go back to 2002 and the Women’s Health Initiative. When early results from that large trial were published, linking a specific combination of conjugated equine estrogen and medroxyprogesterone acetate to raised risks of breast cancer and cardiovascular disease, the reaction was swift and global. A Canadian Medical Association Journal analysis later estimated that hormone therapy prescriptions dropped by as much as eighty percent worldwide in the aftermath. In Canada specifically, hormone therapy use among women aged 45 to 74 fell from roughly 43 percent before the trial to about 11 percent after it.

The fear that drove that drop was real, but the interpretation of the study turned out to be far more complicated than the headlines suggested. A critical detail that was largely lost in the coverage: the average age of women enrolled in the trial was 63, and many were a decade or more past the onset of menopause. The findings applied to that population, not to the younger, recently menopausal women for whom hormone therapy had long been standard care. Subsequent analyses clarified that for healthy women under sixty and within ten years of menopause, the benefits of hormone therapy generally outweigh the risks. But by then the damage to clinical confidence was done, and medical education had moved on.

The fear took root in training programs as thoroughly as it did in practice. Educators who had witnessed the backlash passed their uncertainty on to the next generation of residents, often without revisiting the updated evidence. An editorial by Berga and Garovic, published alongside the landmark US residency study, captured this precisely. It identified the teaching of teachers as the linchpin of the whole problem, and warned that the doctors and patients of tomorrow would be failed if training did not catch up with what the evidence now showed. The menopause knowledge gap, in other words, is not simply a gap in textbooks. It is a gap passed person to person through the medical hierarchy, and it has been moving in that direction for more than twenty years.

Those curriculum gaps have real consequences, and the data on Canadian women makes them visible. A 2025 Canadian study led by University of Alberta researcher Nese Yuksel, drawing on a survey of more than two thousand postmenopausal Canadian women, found that 14.7 percent were living with moderate to severe hot flashes and night sweats. Among those with significant symptoms, two-thirds were receiving no treatment whatsoever, and only about one in ten was using hormone therapy, a rate the researchers noted has barely shifted in years. Most of these women had sought advice. About half were never treated.

The symptoms themselves were far from trivial. Women in the study reported that hot flashes and night sweats cut their work productivity by about thirty percent and weighed on their daily activities even more, while disrupting their sleep consistently. Canadian women in the study scored the highest sleep-disturbance levels of any country in the international survey. When they looked for help, the general practitioner was the provider they turned to most, well ahead of gynaecologists or menopause specialists. Family doctors sit at the centre of menopause care in Canada precisely where the training runs thinnest.

A national survey by the Menopause Foundation of Canada paints the same picture from a different angle. Fewer than one in four women said their family doctor had ever raised menopause with them first. Of those who did go looking for advice, nearly three-quarters found it unhelpful or only somewhat so, and about forty percent felt their symptoms were undertreated. Women named their doctor as their most trusted source of information on menopause, and yet the appointment often did not deliver what they came for.

She trusted her doctor. She asked for help. She left without treatment. For roughly half of Canadian women with serious menopause symptoms, that is the whole story.

Training is only half the story. The other half is how doctors are paid, because that quietly determines how long your appointment is allowed to be. In Ontario, as in most provinces, there is no billing code specifically for menopause, let alone for the far broader and often more disruptive constellation of symptoms that characterize perimenopause: the mood shifts, the anxiety, the broken sleep, the brain fog, the irregular cycles, the joint pain. There is no code that says this visit is complex and deserves more time

A thorough perimenopause consultation takes real time. It means a full symptom history covering hot flashes, sleep, mood, and sexual health; a discussion of hormone therapy and its alternatives; a review of your personal health history and risk factors; and a careful weighing of the options that fit you specifically. A quick prescription takes a few minutes. Under standard fee-for-service billing, the two can pay roughly the same amount. The billing structure does not reward the longer, harder conversation, and in a busy practice that pressure adds up. The Berga and Garovic editorial made this point explicitly, noting that economic incentives to see patients rapidly interfere with both learning and care. That logic carries straight from the teaching hospital into your family doctor’s exam room.

Manitoba is, so far, the only province in Canada with a billing code built specifically for a menopause assessment, one that recognizes the longer, more complex visit and compensates the doctor accordingly. Advocates, among them the Canadian Menopause Society and the Menopause Foundation of Canada, are pushing for other provinces to follow, making the straightforward argument that you cannot expect better menopause care while paying for it as though it were a five-minute problem. Where you live in Canada currently determines what your menopause visit is worth on paper, and what it is worth on paper shapes the care you can realistically get.

When a public system leaves a gap this wide, something moves in to fill it. American researchers Faubion and Shufelt named this space the menopause management vacuum. Into it has rushed a fast-growing private market. The global menopause industry has been valued at around six hundred billion dollars, and compounded hormone products, often marketed as a more natural or personalized alternative despite limited evidence behind them, made up roughly a billion and a half dollars of that market in 2020 alone.

In Canada, the same forces show up as a wave of private and virtual menopause clinics, telehealth services, and subscription products promising the attention the public system is struggling to provide. For women who can afford them and find good practitioners through them, they can be a real help. But the deeper concern is what this two-tier drift means in practice. Canada has a publicly funded health system built on the principle that the quality of your care should not depend on the size of your bank account. A woman with the means to pay out of pocket gets a long, informed menopause consultation. A woman without those means gets a seven-minute appointment and a rushed conversation, or no conversation at all. That is not how Canadian healthcare is supposed to work, and it is worth saying so plainly.

This is where the story turns. The Society of Obstetricians and Gynaecologists of Canada published comprehensive menopause clinical guidelines in 2021 and runs an accredited continuing-education program, Pause for Menopause, designed to help practising clinicians translate those guidelines into everyday care. The Menopause Society offers a certification examination through which clinicians can demonstrate genuine expertise in menopause management, and its public directory lets women search for a certified practitioner in their area. Canadian family physicians have also built practical front-line tools, including the Menopause Quick 6, a six-question screen created precisely because routine training was so thin. In Ontario, a draft provincial quality standard for menopause care has begun naming the problem out loud, acknowledging that trainees feel unprepared and that knowledge gaps lead to women being undertreated.

None of this rebuilds the training pipeline overnight. It does mean the gap is finally being treated as a gap, by the professional bodies with the standing to close it.

Your doctor spent years in medical school. That does not make them the unchallenged authority on your body. Many family doctors were never thoroughly trained in perimenopause, and coming to your appointments informed and ready to direct the conversation is not overstepping. It is what good patient care looks like from your side of the desk. You are allowed to know things, push back, ask hard questions, and expect answers. The research consistently shows that patients who engage actively in their care get better outcomes. That is not a workaround for a broken system. It is how you exercise the right you already have over your own health.

Come in prepared. Write down your symptoms before the appointment: when they happen, how they affect your sleep, your work, and your mood. The Menopause Quick 6 questions make a useful template. A clear picture of what you are experiencing is far more useful to your doctor than a general sense that things are off.

Name what you came to discuss. Use the word perimenopause. Many doctors associate menopause primarily with the end of periods and obvious hot flashes, and may not connect the anxiety, disrupted sleep, or mood changes you are describing to the hormonal transition that is likely driving them. Naming the transition clearly, and asking directly to discuss your options including hormone therapy, signals that you are there for a real conversation.

Ask about hormone therapy directly. Do not wait for your doctor to bring it up. Ask outright whether you are a candidate, what the current evidence says about the risks for someone your age and history, and what the alternatives are. It is also entirely reasonable to ask how comfortable your doctor is with prescribing and managing hormone therapy. If they are not experienced with it, that is useful information, not a confrontation. Doctors cannot be experts in everything, and finding someone with more depth in this area is a legitimate next step, not a slight against anyone.

Do your own research, and bring it. Reading about your options is not overstepping. Understanding your own health history, the treatments available, and the evidence behind them is how you become a genuine partner in your care rather than a passive recipient of it. You know your body. Your doctor knows medicine. The best outcomes usually come from both.

Ask for more time, a follow-up, or a referral. It is reasonable to book a longer or dedicated visit for perimenopause alone. If your doctor refers you to a specialist, know that wait times can be long and referrals are sometimes denied. It is entirely fair to ask your doctor to begin some form of treatment while you wait, rather than leaving you without support in the meantime. You are not being demanding by asking. You are being clear about what your health needs now.

If your perimenopause care has felt inadequate, the most likely explanation is not that your symptoms are imaginary or your doctor indifferent. It is that menopause was largely written out of Canadian medical training after 2002 and has never been fully restored, and that the billing structure in most provinces does not compensate the kind of extended, careful visit this stage of life calls for. That is a system problem, and it is one the research, the professional bodies, and increasingly the patients are naming clearly. Knowing why the gap exists is half the work of navigating it. You deserve thorough care, you are allowed to ask for it directly, and you are not wrong for expecting more than you have been getting.

The key sources behind this article, for anyone who wants to read further:

• Anderson NN, Gagliardi AR. Medical student exposure to women’s health concepts and practices: a content analysis of curriculum at Canadian medical schools. BMC Medical Education, 2021.
• Sinclair N, Skoll A, Ubhi J. Women’s health themes across the undergraduate medical curriculum at the University of British Columbia. Journal of Obstetrics and Gynaecology Canada, 2007.
• McCall MA, Sorbie J. Educating physicians about women’s health: survey of Canadian family medicine residency programs. Canadian Family Physician, 1994.
• Armeni E, et al. Menopause medical education around the world: the way forward to serve women’s health. Current Opinion in Endocrine and Metabolic Research, 2022.
• Kling JM, et al. Menopause management knowledge in postgraduate family medicine, internal medicine, and obstetrics and gynecology residents: a cross-sectional survey (United States). Mayo Clinic Proceedings, 2019.
• Berga SL, Garovic VD. Barriers to the care of menopausal women (editorial). Mayo Clinic Proceedings, 2019.
• Vogel L. Trial overstated HRT risk for younger women. Canadian Medical Association Journal, 2017.
• Pinkerton J. After the Women’s Health Initiative: menopausal women and hormone therapy. AMA Journal of Ethics, 2013.
• Faubion SS, Shufelt CL. The menopause management vacuum. The Cancer Journal, 2022.
• Goldstein S. An efficient tool for the primary care management of menopause (Menopause Quick 6). Canadian Family Physician, 2017.
• Black D. Menopause hormone therapy: 2023 update. Canadian Primary Care Today, 2023.
• Yuksel N, et al. Prevalence and impact of vasomotor symptoms due to menopause among women in Canada: WARM Study subgroup analysis. Menopause, 2025.
• Menopause Foundation of Canada. The Silence and the Stigma: Menopause in Canada, 2022.
• Society of Obstetricians and Gynaecologists of Canada. Menopause Hub and clinical guidelines, 2021.

This article is for informational purposes only and does not constitute medical advice. Always consult your healthcare provider for personal medical guidance.